Wei Guo

6.6k total citations
174 papers, 4.2k citations indexed

About

Wei Guo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wei Guo has authored 174 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Molecular Biology, 50 papers in Oncology and 46 papers in Cancer Research. Recurrent topics in Wei Guo's work include Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (18 papers) and RNA modifications and cancer (14 papers). Wei Guo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (18 papers) and RNA modifications and cancer (14 papers). Wei Guo collaborates with scholars based in China, United States and United Kingdom. Wei Guo's co-authors include Bingliang Fang, Shuhong Wu, Gordon B. Mills, Jie He, Fengwei Tan, Qi Xue, Yibo Gao, Fei Shao, Fuminori Teraishi and Jason J. Davis and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wei Guo

168 papers receiving 4.2k citations

Peers

Countries citing papers authored by Wei Guo

Since Specialization

Citations

This map shows the geographic impact of Wei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Guo more than expected).

Fields of papers citing papers by Wei Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Guo. The network helps show where Wei Guo may publish in the future.

Co-authorship network of co-authors of Wei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Guo. A scholar is included among the top collaborators of Wei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Guo. Wei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer 2025 ·Cancer Communications ·Jiaqi Liang, Guoshu Bi, Xiaolong Huang, Zhijie Xu, Yiwei Huang, Yunyi Bian, Guangyao Shan, Wei Guo, Yuanliang Yan, Qihai Sui, Xiaodong Yang, (unknown), Tao Lu, Huan Zhang, Qun Wang, Wei Jiang, Cheng Zhan	0
2	Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status 2025 ·Nature Communications ·Yunyi Bian, Guangyao Shan, Guoshu Bi, Zhijie Xu, Jiaqi Liang, Yuanliang Yan, Wei Guo, Qihai Sui, (unknown), (unknown), Tao Lu, Huan Zhang, Qun Wang, Hong Fan, Wei Jiang, Cheng Zhan	0
3	Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches 2024 ·Cancer Letters ·Ming Gu, Yang Liu, Xin Peng, Wei Guo, (unknown), (unknown), Ruiyang Ma, (unknown), Wenhui Zheng	7
4	Genomic characteristics and immune landscape of super multiple primary lung cancer 2024 ·EBioMedicine ·Zhenlin Yang, Bolun Zhou, Wei Guo, Peng Yue, He Tian, Jiachen Xu, (unknown), Xiaowei Chen, Bin Hu, Chengming Liu, Zhijie Wang, Chunxiang Li, Shugeng Gao, Jie He	6
5	Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma 2024 ·Nature Communications ·Zhenlin Yang, He Tian, (unknown), Bozhao Li, Guangyu Bai, (unknown), Jiachen Xu, Wei Guo, (unknown), Yue Peng, Qing Liang, Liyan Xue, Shugeng Gao	25
6	Recognition and combination of multiple cell-death features showed good predictive value in lung adenocarcinoma 2023 ·Heliyon ·(unknown), (unknown), Wei Guo, Yong Shi, Wenhui Cheng, (unknown)	1
7	Jingfang granules exert anti-psoriasis effect by targeting MAPK-mediated dendritic cell maturation and PPARγ-mediated keratinocytes cell cycle progression in vitro and in vivo 2023 ·Phytomedicine ·Qingqing Xu, (unknown), (unknown), Zhaoyang Liu, Wei Guo, Tianyu Zhang, (unknown), (unknown), Jingchun Yao, Guimin Zhang, Rong Sun	13
8	Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling 2022 ·EBioMedicine ·Wei Guo, Xin Chen, Rui Liu, Naixin Liang, Qianli Ma, Hua Bao, (unknown), Xue Wu, S Samuel Yang, Yang Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He	32
9	Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma 2022 ·EBioMedicine ·Wei Guo, Bolun Zhou, Zhenlin Yang, Xiang Liu, Qilin Huai, Lei Guo, Xuemin Xue, Fengwei Tan, Yin Li, Qi Xue, Shugeng Gao, Jie He	44
10	WISP1 Protects Against Chondrocyte Senescence and Apoptosis by Regulating αvβ3 and PI3K/Akt Pathway in Osteoarthritis 2021 ·DNA and Cell Biology ·Chao Cheng, Jian Tian, Fangjie Zhang, Zhenhan Deng, Min Tu, Liangjun Li, Hua Yang, (unknown), Wei Guo, Ruiqi Yang, Shuguang Gao, Zhihong Zhou	13
11	Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics 2020 ·DNA and Cell Biology ·Wei Guo, Sijin Sun, Lei Guo, Peng Song, Xuemin Xue, Hao Zhang, Guochao Zhang, Renda Li, Yibo Gao, Bin Qiu, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He	19
12	Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells 2018 ·Clinical Cancer Research ·Fiona Simpkins, Kibeom Jang, Hyunho Yoon, (unknown), (unknown), Diana J. Azzam, Jun Sun, Dekuang Zhao, Tan A. Ince, Wenbin Liu, Wei Guo, Zhi Wei, Gao Zhang, Gordon B. Mills, Joyce M. Slingerland	57
13	YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K Pathway 2017 ·Cancer Research ·Chao Wang, Chao Gu, Kang Jin Jeong, Dong Zhang, Wei Guo, Yiling Lu, Zhenlin Ju, Nattapon Panupinthu, Ji Yeon Yang, Mihai Gagea, Patrick Kwok Shing Ng, Fan Zhang, Gordon B. Mills	43
14	NOTCH1 Signaling Regulates Self-Renewal and Platinum Chemoresistance of Cancer Stem–like Cells in Human Non–Small Cell Lung Cancer 2017 ·Cancer Research ·Yun Zhang, Wei Xu, Huiqin Guo, Yanmei Zhang, (unknown), Sau Har Lee, Xin Song, Xiaoyan Li, Yongqing Guo, Yunlong Zhao, Cheng Ding, (unknown), Yuanyuan Ma, Qun‐Ying Lei, Xiaoyu Hu, Shengnan Li, Wei Guo	75
15	Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer 2013 ·Biomarkers ·(unknown), Wei Guo, Bingshan Liu, Linlin Sun, (unknown), Li Zhu, Xinyan Wang, Bin Liu, Qian Xie, Ke Li	14
16	Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1 H -indole-3-carboxaldehyde (oncrasin-1) 2009 ·Molecular Cancer Therapeutics ·Wei Guo, Shuhong Wu, Li Wang, (unknown), Xiaoli Wei, Jinsong Liu, Bingliang Fang	23
17	Subproteomic analysis of the mitochondrial proteins in rats 24 h after partial hepatectomy 2008 ·Journal of Cellular Biochemistry ·(unknown), Mingyong Miao, Xuan Jia, Wei Guo, Lianghua Wang, Zhenzhen Yao, Chunli Liu, Binghua Jiao	17
18	DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area. 2007 ·PubMed ·Xu Guo, (unknown), (unknown), (unknown), (unknown), Wei Guo	19
19	[Correlations of XRCC5 polymorphisms to genetic susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a high incidence region]. 2007 ·PubMed ·(unknown), Na Wang, Wei Guo, Rong‐Miao Zhou, Xiaojuan Zhang, Yan Li	5
20	[Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer]. 2007 ·PubMed ·Xiao Su, Xin Wang, (unknown), Hao Long, Jian Fu, Peng Lin, (unknown), (unknown), (unknown), Wei Guo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact